The Hain Celestial Group Inc (Hain Celestial) manufactures, markets, distributes, and sells natural and organic products. The company operates in the food and personal care industries, offering products such as beverages, yogurt, baby and kid’s foods, meal preparation items, and personal care products. The company sells its products through supermarkets, specialty and natural food distributors, natural food stores, foodservice channels, mass-market and e-commerce retailers, and club, drug, and convenience stores.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Hain Celestial continuously seeks to understand consumers and develop products that address changing consumer needs. The company's research and development staff routinely reformulates and improves existing products based on advances in ingredients, packaging, and technology. In addition to company-sponsored research and development activities, the company may partner with contract manufacturers to quickly and economically introduce new products to market. The company also collaborates with certain customers on exclusive customer initiatives. The R&D unit of Hain Celestial is responsible for developing new products, reformulating and improving existing products, and ensuring compliance with governmental regulations. The unit plays a crucial role in anticipating changes in consumer preferences and supporting the company's go-to-market strategy. In FY2026, the company incurred an expense of US$6.1 million on its R&D activities, which grew 17.3%YoY and stood at 0.5% of the company’s total revenue.